drotaverin and Chronic-Disease

drotaverin has been researched along with Chronic-Disease* in 3 studies

Trials

1 trial(s) available for drotaverin and Chronic-Disease

Article	Year
[Rheohepatographic changes under the effect of clinical trials of drugs in chronic nonspecific lung diseases]. Terapevticheskii arkhiv, 1980, Volume: 52, Issue:7 Topics: Aminophylline; Asthma; Bronchitis; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic; Ephedrine; Humans; Isoproterenol; Liver Circulation; Papaverine; Plethysmography, Impedance; Pneumonia; Strophanthins	1980

Other Studies

2 other study(ies) available for drotaverin and Chronic-Disease

Article	Year
[New approaches to diagnosing and treating hyperkinetic biliary dyskinesia associated with chronic acalculous cholecystitis]. Klinicheskaia meditsina, 2004, Volume: 82, Issue:9 Ninety patients aged 21 to 56 years who had chronic non-calculous cholecystitis (CNCC) concurrent with hyperkinetic dyskinesia (HKD) detectable by a stepwise duodenal probing and sonography, by using a choleretic breakfast and by determining the relaxation coefficient (RC) that was equal to the ratio of the volume of the gallbladder (GB) after the use of a spasmolytic to the baseline GB volume. The patients were divided into 3 groups. The authors used as a spasmolytic agent pinaverium bromide (dicetel) in a dose of 50 mg (1 tablet) in Group 1), octylonium bromide (spasmomen) in a dose of 40 mg (1 dragee) in Group 2, and drotaverine (no-spa) in a dose of 40 mg (1 tablet). There was a more significant sonographic increase in the size of GB in Groups 1 and 2 as compared with Group 3. In the acute drug test and during long-term treatment as well, the highest spasmolytic effect was noted in patients receiving dicetel (Group 1) and spasmomen (Group 2) as compared with that in Group 3 patients taking drotaverine. With this, RC was 1.25 +/- 0.2, 1.6 +/- 0.15, and 1.08 +/- 0.1, respectively. No adverse reactions occurred in the patients having selective calcium blockers (SCBs) whereas the patients receiving no-spa were found to have the following side effects: dry mouth (n = 3), transient constipation (n = 1), and numb tongue (n = 1). Thus, the study has provided evidence for the fact that SCBs have some advantage over myotropic spasmolytic agents in the treatment of CNCC with the signs of HKD. Topics: Acalculous Cholecystitis; Adult; Biliary Dyskinesia; Calcium Channel Blockers; Chronic Disease; Female; Humans; Male; Middle Aged; Morpholines; Papaverine; Parasympatholytics; Quaternary Ammonium Compounds; Time Factors; Treatment Outcome; Ultrasonography	2004
[Clinical x-ray diagnosis of an elongated large intestine]. Vrachebnoe delo, 1983, Issue:5 Topics: Adult; Aged; Atropine; Chronic Disease; Diagnosis, Differential; Female; Gastrointestinal Neoplasms; Humans; Intestine, Large; Male; Middle Aged; Neostigmine; Palpation; Papaverine; Radiography	1983

Article

Year

[New approaches to diagnosing and treating hyperkinetic biliary dyskinesia associated with chronic acalculous cholecystitis].

Klinicheskaia meditsina, 2004, Volume: 82, Issue:9

Ninety patients aged 21 to 56 years who had chronic non-calculous cholecystitis (CNCC) concurrent with hyperkinetic dyskinesia (HKD) detectable by a stepwise duodenal probing and sonography, by using a choleretic breakfast and by determining the relaxation coefficient (RC) that was equal to the ratio of the volume of the gallbladder (GB) after the use of a spasmolytic to the baseline GB volume. The patients were divided into 3 groups. The authors used as a spasmolytic agent pinaverium bromide (dicetel) in a dose of 50 mg (1 tablet) in Group 1), octylonium bromide (spasmomen) in a dose of 40 mg (1 dragee) in Group 2, and drotaverine (no-spa) in a dose of 40 mg (1 tablet). There was a more significant sonographic increase in the size of GB in Groups 1 and 2 as compared with Group 3. In the acute drug test and during long-term treatment as well, the highest spasmolytic effect was noted in patients receiving dicetel (Group 1) and spasmomen (Group 2) as compared with that in Group 3 patients taking drotaverine. With this, RC was 1.25 +/- 0.2, 1.6 +/- 0.15, and 1.08 +/- 0.1, respectively. No adverse reactions occurred in the patients having selective calcium blockers (SCBs) whereas the patients receiving no-spa were found to have the following side effects: dry mouth (n = 3), transient constipation (n = 1), and numb tongue (n = 1). Thus, the study has provided evidence for the fact that SCBs have some advantage over myotropic spasmolytic agents in the treatment of CNCC with the signs of HKD.

Topics: Acalculous Cholecystitis; Adult; Biliary Dyskinesia; Calcium Channel Blockers; Chronic Disease; Female; Humans; Male; Middle Aged; Morpholines; Papaverine; Parasympatholytics; Quaternary Ammonium Compounds; Time Factors; Treatment Outcome; Ultrasonography

2004

[Clinical x-ray diagnosis of an elongated large intestine].

Vrachebnoe delo, 1983, Issue:5

Topics: Adult; Aged; Atropine; Chronic Disease; Diagnosis, Differential; Female; Gastrointestinal Neoplasms; Humans; Intestine, Large; Male; Middle Aged; Neostigmine; Palpation; Papaverine; Radiography

1983